Stocks
Aura Biosciences, Inc.AURA
NASDAQHealthcareBiotechnology$6.30
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted therapies for oncology, with a lead candidate designed to treat uveal melanoma and other solid tumors. Its virus-like drug conjugate platform aims to deliver tumor-specific cell death while preserving healthy tissue, a differentiation investors track closely. The company's progress through clinical trials and regulatory milestones drives its valuation.
52W Range: $4.73-$9.54
Congressional Interest in Aura Biosciences, Inc. (AURA)
No congressional trades have been disclosed for Aura Biosciences, Inc. (AURA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AURA?
No congressional trades found for this stock.